$上海莱士(SZ002252)$
Shares in Grifols rose Wednesday after it said it is planning to reduce its shareholding in Shanghai RAAS Blood Products and that it expects to receive $1.5 billion from the move.
Grifols的股价周三上涨，此前该公司表示计划减少在上海RAAS血液制品公司的股份，预计此举将获得15亿美元。
At 1010 GMT, shares in Grifols were up 8% to EUR11.96.
格林威治标准时间10点10分，Grifols的股价上涨了8％，至11.96欧元。
The Spanish pharmaceutical company said it has notified the Chinese pharmaceutical firm and that the matter is still in planning stages.
这家西班牙制药公司表示，已通知这家中国制药公司，此事仍处于计划阶段。
Grifols, which currently is the largest shareholder in Shanghai RAAS, said it will remain a significant shareholder in the Chinese company.
目前是上海RAAS的最大股东的Grifols表示，它将继续是这家中国公司的重要股东。